316 related articles for article (PubMed ID: 38641945)
1. Multi-omics technologies and molecular biomarkers in brain tumor-related epilepsy.
Du Y; Li R; Fu D; Zhang B; Cui A; Shao Y; Lai Z; Chen R; Chen B; Wang Z; Zhang W; Chu L
CNS Neurosci Ther; 2024 Apr; 30(4):e14717. PubMed ID: 38641945
[TBL] [Abstract][Full Text] [Related]
2. Correlation of Clinicopathological Factors with Brain Tumor-Related Epilepsy in Glioma.
Wang Z; Yang W; Wang Y; Aili Y; Wang Z; Wang Q; Jiang S; Zhang G; Zhang J; Li B
Dis Markers; 2022; 2022():4918294. PubMed ID: 36246555
[TBL] [Abstract][Full Text] [Related]
3. [OMICS and biomarkers of glial tumors].
Idbaih A
Rev Neurol (Paris); 2011 Oct; 167(10):691-8. PubMed ID: 21889780
[TBL] [Abstract][Full Text] [Related]
4. Biomarkers related with seizure risk in glioma patients: A systematic review.
Zhou XW; Wang X; Yang Y; Luo JW; Dong H; Liu YH; Mao Q
Clin Neurol Neurosurg; 2016 Dec; 151():113-119. PubMed ID: 27821299
[TBL] [Abstract][Full Text] [Related]
5. Significance of miR-196b in tumor-related epilepsy of patients with gliomas.
You G; Yan W; Zhang W; Wang Y; Bao Z; Li S; Li S; Li G; Song Y; Kang C; Jiang T
PLoS One; 2012; 7(9):e46218. PubMed ID: 23049982
[TBL] [Abstract][Full Text] [Related]
6. An analysis of 170 glioma patients and systematic review to investigate the association between IDH-1 mutations and preoperative glioma-related epilepsy.
Yang Y; Mao Q; Wang X; Liu Y; Mao Y; Zhou Q; Luo J
J Clin Neurosci; 2016 Sep; 31():56-62. PubMed ID: 27406953
[TBL] [Abstract][Full Text] [Related]
7. Quality of life, mood and seizure control in patients with brain tumor related epilepsy treated with lacosamide as add-on therapy: A prospective explorative study with a historical control group.
Maschio M; Zarabla A; Maialetti A; Fabi A; Vidiri A; Villani V; Giannarelli D
Epilepsy Behav; 2017 Aug; 73():83-89. PubMed ID: 28623754
[TBL] [Abstract][Full Text] [Related]
8. FOXO4 expression is associated with the occurrence and outcome of seizures: An RNA-sequencing analysis of low-grade gliomas.
Wang Y; Tang K; Zhao J; Liu L; Feng J
Seizure; 2017 Nov; 52():41-45. PubMed ID: 28963932
[TBL] [Abstract][Full Text] [Related]
9. IDH1 and IDH2 mutations in postoperative diffuse glioma-associated epilepsy.
Neal A; Kwan P; O'Brien TJ; Buckland ME; Gonzales M; Morokoff A
Epilepsy Behav; 2018 Jan; 78():30-36. PubMed ID: 29172136
[TBL] [Abstract][Full Text] [Related]
10. Clinical Characteristics of BRAF V600E Gene Mutation in Patients of Epilepsy-Associated Brain Tumor: a Meta-analysis.
Xing H; Song Y; Zhang Z; Koch PD
J Mol Neurosci; 2021 Sep; 71(9):1815-1824. PubMed ID: 33791912
[TBL] [Abstract][Full Text] [Related]
11. Multi-omics integration and epilepsy: Towards a better understanding of biological mechanisms.
Chong D; Jones NC; Schittenhelm RB; Anderson A; Casillas-Espinosa PM
Prog Neurobiol; 2023 Aug; 227():102480. PubMed ID: 37286031
[TBL] [Abstract][Full Text] [Related]
12. Lacosamide on background eeg activity in brain tumor-related epilepsy patients: A case series study.
Maschio M; Zarabla A; Maialetti A; Sperati F; Dinapoli L; Dispenza S; Petreri G; Cantelmi T
Brain Behav; 2018 Nov; 8(11):e01067. PubMed ID: 30334378
[TBL] [Abstract][Full Text] [Related]
13. Management of epilepsy in brain tumor patients.
van der Meer PB; Taphoorn MJB; Koekkoek JAF
Curr Opin Oncol; 2022 Nov; 34(6):685-690. PubMed ID: 35838207
[TBL] [Abstract][Full Text] [Related]
14. BRAF V600E mutation in epilepsy-associated glioneuronal tumors: Prevalence and correlation with clinical features in a Chinese population.
Zhang YX; Shen CH; Guo Y; Zheng Y; Zhu JM; Ding Y; Tang YL; Wang S; Ding MP
Seizure; 2017 Feb; 45():102-106. PubMed ID: 27984807
[TBL] [Abstract][Full Text] [Related]
15. Epilepsy in patients with gliomas: incidence and control of seizures.
Iuchi T; Hasegawa Y; Kawasaki K; Sakaida T
J Clin Neurosci; 2015 Jan; 22(1):87-91. PubMed ID: 25192590
[TBL] [Abstract][Full Text] [Related]
16. Molecular Classification of Gliomas is Associated with Seizure Control: A Retrospective Analysis.
Easwaran TP; Lancki N; Henriquez M; Vortmeyer AO; Barbaro NM; Scholtens DM; Ahmed AU; Dey M
Neuromolecular Med; 2021 Jun; 23(2):315-326. PubMed ID: 33206320
[TBL] [Abstract][Full Text] [Related]
17. High expression of cystine-glutamate antiporter xCT (SLC7A11) is an independent biomarker for epileptic seizures at diagnosis in glioma.
Sørensen MF; Heimisdóttir SB; Sørensen MD; Mellegaard CS; Wohlleben H; Kristensen BW; Beier CP
J Neurooncol; 2018 May; 138(1):49-53. PubMed ID: 29404978
[TBL] [Abstract][Full Text] [Related]
18. BCL2A1 is a potential biomarker for postoperative seizure control in patients with low-grade gliomas.
You G; Feng L; Yan W; Zhang W; Wang YZ; Li SW; Li SW; Li GL; Song YJ; Kang CS; You YP; Jiang T
CNS Neurosci Ther; 2013 Nov; 19(11):882-8. PubMed ID: 23841872
[TBL] [Abstract][Full Text] [Related]
19. Gliomas and seizures.
Prakash O; Lukiw WJ; Peruzzi F; Reiss K; Musto AE
Med Hypotheses; 2012 Nov; 79(5):622-6. PubMed ID: 22959996
[TBL] [Abstract][Full Text] [Related]
20. Deficiency of very large G-protein-coupled receptor-1 is a risk factor of tumor-related epilepsy: a whole transcriptome sequencing analysis.
Wang Y; Fan X; Zhang W; Zhang C; Wang J; Jiang T; Wang L
J Neurooncol; 2015 Feb; 121(3):609-16. PubMed ID: 25511798
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
